Omeros claims a failed drug study was ‘positive.’ Investors were not fooled
A biotech claimed to have “positive” clinical trial results. The results were, well, not.
During our last week, I warned investors to be wary of biotechs that claim to have “positive” clinical trial results in the headline of their press
